Approval · Notice of Compliance 26460 · 2021
TYBOST: Notice of Compliance 26460
Issued August 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26460
- Date
- August 18, 2021
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) with respect to potential interaction with cutaneously-administered corticosteroids sensitive to cytochrome P450 (CYP) 3A inhibition. To convert the PM to the 2020 Product Monograph format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYBOST | Not yet assigned | — |
Medicinal ingredients
- COBICISTAT 150 MG per TAB